Short Interest in Synthetic Biologics Expands By 42.7% (SYN)
Shares of Synthetic Biologics (NYSE:SYN) were the target of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 3,174,134 shares, a growth of 42.7% from the July 31st total of 2,224,409 shares, AR Network reports. Based on an average daily volume of 512,423 shares, the days-to-cover ratio is currently 6.2 days. Approximately 10.0% of the shares of the company are sold short.
Shares of Synthetic Biologics (NYSE:SYN) traded down 1.30% on Tuesday, hitting $2.27. 490,164 shares of the company’s stock traded hands. Synthetic Biologics has a 52-week low of $0.95 and a 52-week high of $3.64. The stock has a 50-day moving average of $1.71 and a 200-day moving average of $2.02. The company’s market cap is $132.7 million.
Synthetic Biologics (NYSE:SYN) last announced its earnings results on Thursday, August 14th. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.06) by $0.02. On average, analysts predict that Synthetic Biologics will post $-0.24 earnings per share for the current fiscal year.
Synthetic Biologics, Inc, formerly Adeona Pharmaceuticals, Inc, is a biotechnology company focused on the development of synthetic deoxyribonucleic acid (NYSE:SYN)-based therapeutics and disease-modifying medicines for serious illnesses.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.